explore -WSS

explore

author：comprehensive 2025-09-29 21:13:07 - browse：7523

Are there still too many biotech companies? How do you know when you’re in a bubble? And is there a wrong way to pronounce “TIGIT”?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Josh Schimmer and Eric Schmidt, two longtime analysts teaming up at Cantor Fitzgerald, join us for a back-to-school conversation as biotech enters the busy back third of 2023. We also discuss the latest news in the life sciences, including some scientific evolution at Biogen, new leadership at Illumina, and the future of CRISPR medicine.

For more on what we cover, here’s the news from Biogen; here’s more on Illumina; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： DeSantis can now import cheaper drugs. But will Biden get credit?

WSS

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

New Medicare drug pricing powers could soon be upended in court

GSK to buy asthma

New Medicare drug pricing powers could soon be upended in court

explore

explore

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Hepatitis C has a cure — but many Americans still lack access to it

Heart disease and mental health: A look at cardiac psychology

Alkermes shareholders re

Weight loss drugs aren’t covered by Obamacare. That may change

DIEP, the 'gold standard' of breast reconstruction, is under threat

Idaho abortion case may prompt more restrictions in other states

Bright Health sells Medicare Advantage business to Molina

Heart disease and mental health: A look at cardiac psychology

leisure time

Abridge raises $150m as clinical notes automation market heats up

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

New CMS data security rules will hurt Medicare, Medicaid research

Risky weight loss products often used by teens globally, per study

New menopause drug shows promise in relief for hot flashes

The nurse manager staffing crisis is hurting patients

focus

focus

entertainment

entertainment